HGF and Myocardial fibrosis: Interestingly, HGF inhibition using anti-HGF antibodies in BMPC treated mice showed pronounced elevation of miR-155 expression (Figure 3, P<0.05 vs IgG-treated mice) in association with increased myocardial fibrosis (Figure 4; P<0.05), depressed cardiac function (reduced %EF; Figure 5; P<0.05) and increased mRNA expression of fibrotic markers (Figure 6) as compared to IgG treated mice.